EGFR and neoplasm: The low rates of EGFR and KRAS mutations may reflect a higher rate of false-negative results due to the low tumor cell percentage in proportion to non-neoplastic cells in these lymph nodes, although areas of high tumor cellularity were specifically selected for DNA isolation.